Gillian Atkinson

Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study

Francesca Ferrua, Maria Pia Cicalese, Stefania Galimberti et al. · The Lancet Haematology · 2019 · 200 citations · Full text

A double blind, placebo‐controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection

Janice Main, Jonathan Brown, C. H. L. Howells et al. · Journal of Viral Hepatitis · 1996 · 127 citations

Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trial

David H. Miller, Thomas Weber, Richard Grove et al. · The Lancet Neurology · 2012 · 77 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +8

A controlled trial of 6-weeks' treatment with a novel inhaled phosphodiesterase type-4 inhibitor in COPD

Jørgen Vestbo, Lan‐Eng Tan, Gillian Atkinson et al. · European Respiratory Journal · 2009 · 67 citations · Full text

Study Design: Human Leukocyte Antigen Class I Molecule A∗02-Chimeric Antigen Receptor Regulatory T Cells in Renal Transplantation

Katharina Schreeb, Emily J Culme-Seymour, Essra Ridha et al. · Kidney International Reports · 2022 · 57 citations · Full text